Pituitary Disorders & Hormonal Conditions
Specialist assessment and management of pituitary tumours and hormonal conditions, including prolactinoma, Cushing's disease, growth hormone deficiency, and hypopituitarism.
Specialist assessment and management of pituitary tumours and hormonal conditions, including prolactinoma, Cushing's disease, growth hormone deficiency, and hypopituitarism.
The pituitary gland is a small, pea-sized gland at the base of the brain, sitting in a bony cavity called the sella turcica. Despite its tiny size, it is often called the "master gland" because it regulates the output of most other endocrine glands in the body — controlling thyroid hormone production, adrenal function, growth, reproduction, and water balance.
Pituitary disorders arise when tumours, inflammation, or damage disrupt this regulatory function — either causing excess hormone secretion (functioning tumours) or impairing hormone production (hypopituitarism). Some conditions affect adjacent structures, causing headaches or visual disturbance. Many pituitary abnormalities are discovered incidentally on brain imaging performed for other reasons — a finding known as a pituitary incidentaloma.
Many of these conditions require coordination with neurosurgery, neuro-ophthalmology, and clinical oncology. We provide specialist endocrine input as part of a multidisciplinary approach.
Assessment and management of prolactin-secreting pituitary adenomas, including medical treatment with dopamine agonists, monitoring for tumour response, and assessment of hypogonadism and fertility implications.
Evaluation of ACTH-dependent hypercortisolism caused by a pituitary corticotroph adenoma. Collaboration with neurosurgery where pituitary surgery is indicated, and post-treatment surveillance.
Assessment of adult growth hormone deficiency in patients with pituitary disease or history of cranial irradiation, including dynamic testing and, where appropriate, growth hormone replacement therapy.
Structured evaluation of incidentally discovered pituitary lesions, including hormonal assessment for secretory activity, assessment for hypopituitarism, and surveillance imaging planning.
Management of partial or complete pituitary hormone deficiency, including thyroxine, hydrocortisone, testosterone or oestrogen, and growth hormone replacement where indicated, with careful monitoring.
Endocrine surveillance following transsphenoidal pituitary surgery, including assessment for remission or recurrence, management of new pituitary hormone deficiencies, and long-term surveillance planning.
Assessment of pituitary disorders combines hormonal blood tests with imaging. Hormonal evaluation typically includes prolactin, IGF-1 (as a marker of growth hormone excess), morning cortisol, ACTH, gonadotrophins (LH, FSH), thyroid function, and sex hormones. Interpretation requires careful attention to pre-analytical factors — many pituitary hormones fluctuate significantly.
Dynamic tests — including insulin tolerance testing, synacthen stimulation testing, and oral glucose tolerance testing for acromegaly — are used when basal tests are inconclusive. MRI pituitary with gadolinium contrast is the gold-standard imaging modality for identifying and characterising pituitary lesions.
All pituitary consultations are led by Dr Syed Kashif Hussain Kazmi, Consultant Endocrinologist (IMC: 213626), with comprehensive pituitary assessment and close collaboration with neurosurgical and neuro-radiology services when required.
Book a private pituitary consultation with Dr Kazmi, Consultant Endocrinologist. Thorough assessment with access to specialist investigation and multidisciplinary input.